AB.PA
AB Science SA
Price:  
1.22 
EUR
Volume:  
246,634.00
France | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AB.PA EV/EBITDA

-193.0%
Upside

As of 2025-11-02, the EV/EBITDA ratio of AB Science SA (AB.PA) is -13.66. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AB.PA's latest enterprise value is 92.12 mil EUR. AB.PA's TTM EBITDA according to its financial statements is -6.75 mil EUR. Dividing these 2 quantities gives us the above AB.PA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 3.6x - 6.6x 6.5x
Forward P/E multiples 10.6x - 11.5x 10.8x
Fair Price (1.34) - (0.92) (1.14)
Upside -209.5% - -175.1% -193.0%
1.22 EUR
Stock Price
(1.14) EUR
Fair Price

AB.PA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-10-29 -13.11
2025-10-28 -13.19
2025-10-27 -13.32
2025-10-24 -13.45
2025-10-23 -13.45
2025-10-22 -13.68
2025-10-21 -14.02
2025-10-20 -14.04
2025-10-17 -14.24
2025-10-16 -15.45
2025-10-15 -15.85
2025-10-14 -15.93
2025-10-13 -14.38
2025-10-10 -15.06
2025-10-09 -15.41
2025-10-08 -15.23
2025-10-07 -15.15
2025-10-06 -14.75
2025-10-03 -14.56
2025-10-02 -14.09
2025-10-01 -14.09
2025-09-30 -14.00
2025-09-29 -13.81
2025-09-26 -13.90
2025-09-25 -13.92
2025-09-24 -14.05
2025-09-23 -13.96
2025-09-22 -14.38
2025-09-19 -14.17
2025-09-18 -13.90
2025-09-17 -13.71
2025-09-16 -13.85
2025-09-15 -13.81
2025-09-12 -13.56
2025-09-11 -13.81
2025-09-10 -13.66
2025-09-09 -13.49
2025-09-08 -13.37
2025-09-05 -13.39
2025-09-04 -13.56
2025-09-03 -13.71
2025-09-02 -13.53
2025-09-01 -14.85
2025-08-29 -13.39
2025-08-28 -13.47
2025-08-27 -13.60
2025-08-26 -13.43
2025-08-25 -14.00
2025-08-22 -14.28
2025-08-21 -14.34